TP53 and neoplasm: In summary, our results demonstrated that cisatracurium could upregulate p53 to promote lincRNA-p21, and then inhibit miR-181b, to suppress the proliferation, migration and invasion of OVCAR-3 cells and induce tumor cell apoptosis.